WCC News - January 2013
Wilmot Cancer Center Welcomes Elizabeth Guancial, M.D.
The Genitourinary Cancer team at the Wilmot Cancer Center welcomed Elizabeth Guancial, M.D. to its ranks on January 1. Elizabeth will serve as an Assistant Professor in Medicine, Hematology/Oncology, in the Department of Medicine.
She joins the Wilmot faculty after having completed a Fellowship at the Dana Farber Cancer Institute. Prior to that, Elizabeth completed a residency in the Department of Internal Medicine at Massachusetts General Hospital. She earned her medical doctorate at Harvard Medical School, and an undergraduate degree from Hamilton College, where she graduated summa cum laude.
A former Buffalo resident, Elizabeth has significant experience in research related to bladder cancer and other GU cancers and was awarded a Bladder Cancer Research Award by the Bladder Cancer Advocacy Network. She currently serves as a peer reviewer for the European Oncology & Haematology journal and the British Journal of Urology.
Cancer Center Awards $350,000 in Seed Grants
The Wilmot Cancer Center recently reviewed applications for Pilot Project, Program and Neuroblastoma grants totaling $350,000. Applications were reviewed by teams from the Research Advisory Committee (RAC), resulting in the following awards:
Pilot Project Seed Grants: Three awards of $50,000 each
Fifteen Pilot Project applications were received and reviewed by 10 members of the RAC. Each application was reviewed by at least three individuals. The teams then narrowed the review process to what they had determined as the top 10 applications. Those top 10 were then scored and outcome reviewed. The group selected the top three scoring applications to receive $50,000 seed grants. They included:
Program Grant: $100,000/$50,000
Five Program Grant applications were received and reviewed by a group of three RAC members. The top scoring application was the Multidisciplinary Oncology Research (MORe), submitted by Katia Noyes, and John Monson, who were awarded $100,000 for the program. A Breast Cancer Program application submitted by Helene McMurray and Mark Noble also scored highly, and the reviewers felt that the potential of the program merited a $50,000 grant.
Neuroblastoma Grant: $50,000
There were two Neuroblastoma Grant applications received. The grant was awarded to Mark Noble for his New Therapeutic Approaches to Neuroblastoma proposal.